nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CALM1—Alzheimer's disease	0.328	0.805	CbGaD
Nicardipine—CYP2D6—Alzheimer's disease	0.0797	0.195	CbGaD
Nicardipine—CYP2B6—Memantine—Alzheimer's disease	0.0553	0.205	CbGbCtD
Nicardipine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0386	0.143	CbGbCtD
Nicardipine—CYP2C19—Memantine—Alzheimer's disease	0.0351	0.13	CbGbCtD
Nicardipine—CYP2C9—Donepezil—Alzheimer's disease	0.0337	0.125	CbGbCtD
Nicardipine—CYP2D6—Donepezil—Alzheimer's disease	0.0308	0.114	CbGbCtD
Nicardipine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0245	0.0908	CbGbCtD
Nicardipine—CYP2D6—Galantamine—Alzheimer's disease	0.0199	0.0735	CbGbCtD
Nicardipine—CYP3A4—Donepezil—Alzheimer's disease	0.0196	0.0726	CbGbCtD
Nicardipine—CYP3A4—Galantamine—Alzheimer's disease	0.0126	0.0468	CbGbCtD
Nicardipine—PDE1B—forebrain—Alzheimer's disease	0.00153	0.0306	CbGeAlD
Nicardipine—PDE1B—telencephalon—Alzheimer's disease	0.00141	0.0281	CbGeAlD
Nicardipine—PDE1A—forebrain—Alzheimer's disease	0.00129	0.0256	CbGeAlD
Nicardipine—PDE1A—telencephalon—Alzheimer's disease	0.00118	0.0236	CbGeAlD
Nicardipine—CALM2—blood vessel—Alzheimer's disease	0.000953	0.019	CbGeAlD
Nicardipine—CALM1—blood vessel—Alzheimer's disease	0.000949	0.0189	CbGeAlD
Nicardipine—CACNA2D1—forebrain—Alzheimer's disease	0.00089	0.0177	CbGeAlD
Nicardipine—CACNB2—telencephalon—Alzheimer's disease	0.000872	0.0174	CbGeAlD
Nicardipine—PDE1B—nervous system—Alzheimer's disease	0.000833	0.0166	CbGeAlD
Nicardipine—CACNA1D—forebrain—Alzheimer's disease	0.000828	0.0165	CbGeAlD
Nicardipine—ADRA1D—forebrain—Alzheimer's disease	0.000821	0.0164	CbGeAlD
Nicardipine—PDE1B—central nervous system—Alzheimer's disease	0.000802	0.016	CbGeAlD
Nicardipine—PDE1B—cerebellum—Alzheimer's disease	0.000784	0.0156	CbGeAlD
Nicardipine—CACNA1C—forebrain—Alzheimer's disease	0.000765	0.0152	CbGeAlD
Nicardipine—CACNA1D—telencephalon—Alzheimer's disease	0.000762	0.0152	CbGeAlD
Nicardipine—ADRA1D—telencephalon—Alzheimer's disease	0.000755	0.0151	CbGeAlD
Nicardipine—CACNA1C—telencephalon—Alzheimer's disease	0.000703	0.014	CbGeAlD
Nicardipine—PDE1A—nervous system—Alzheimer's disease	0.000698	0.0139	CbGeAlD
Nicardipine—PDE1A—central nervous system—Alzheimer's disease	0.000672	0.0134	CbGeAlD
Nicardipine—PDE1A—cerebellum—Alzheimer's disease	0.000657	0.0131	CbGeAlD
Nicardipine—CHRM4—nervous system—Alzheimer's disease	0.000638	0.0127	CbGeAlD
Nicardipine—PDE1B—brain—Alzheimer's disease	0.000637	0.0127	CbGeAlD
Nicardipine—CHRM2—forebrain—Alzheimer's disease	0.000631	0.0126	CbGeAlD
Nicardipine—CHRM4—central nervous system—Alzheimer's disease	0.000615	0.0122	CbGeAlD
Nicardipine—Atrial fibrillation—Donepezil—Alzheimer's disease	0.000609	0.00444	CcSEcCtD
Nicardipine—Felodipine—CALM1—Alzheimer's disease	0.000604	0.244	CrCbGaD
Nicardipine—Polyuria—Memantine—Alzheimer's disease	0.000596	0.00435	CcSEcCtD
Nicardipine—Pollakiuria—Galantamine—Alzheimer's disease	0.000594	0.00433	CcSEcCtD
Nicardipine—CALM3—telencephalon—Alzheimer's disease	0.000589	0.0117	CbGeAlD
Nicardipine—Nifedipine—CALM1—Alzheimer's disease	0.000584	0.236	CrCbGaD
Nicardipine—Polyuria—Rivastigmine—Alzheimer's disease	0.000583	0.00426	CcSEcCtD
Nicardipine—CHRM2—telencephalon—Alzheimer's disease	0.00058	0.0116	CbGeAlD
Nicardipine—CHRM1—forebrain—Alzheimer's disease	0.000574	0.0114	CbGeAlD
Nicardipine—CALM2—embryo—Alzheimer's disease	0.000569	0.0113	CbGeAlD
Nicardipine—CALM1—embryo—Alzheimer's disease	0.000566	0.0113	CbGeAlD
Nicardipine—Hot flush—Memantine—Alzheimer's disease	0.00056	0.00408	CcSEcCtD
Nicardipine—Face oedema—Donepezil—Alzheimer's disease	0.000557	0.00406	CcSEcCtD
Nicardipine—Menopausal symptoms—Memantine—Alzheimer's disease	0.000555	0.00405	CcSEcCtD
Nicardipine—Atrial fibrillation—Memantine—Alzheimer's disease	0.000553	0.00403	CcSEcCtD
Nicardipine—Hot flush—Rivastigmine—Alzheimer's disease	0.000548	0.00399	CcSEcCtD
Nicardipine—Haematuria—Galantamine—Alzheimer's disease	0.000547	0.00399	CcSEcCtD
Nicardipine—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.000543	0.00396	CcSEcCtD
Nicardipine—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.000541	0.00394	CcSEcCtD
Nicardipine—PDE1A—brain—Alzheimer's disease	0.000533	0.0106	CbGeAlD
Nicardipine—CHRM1—telencephalon—Alzheimer's disease	0.000528	0.0105	CbGeAlD
Nicardipine—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000527	0.00384	CcSEcCtD
Nicardipine—Hypokalaemia—Donepezil—Alzheimer's disease	0.000525	0.00383	CcSEcCtD
Nicardipine—Rhinitis—Galantamine—Alzheimer's disease	0.000516	0.00377	CcSEcCtD
Nicardipine—CACNB2—nervous system—Alzheimer's disease	0.000515	0.0103	CbGeAlD
Nicardipine—CHRM3—forebrain—Alzheimer's disease	0.000514	0.0102	CbGeAlD
Nicardipine—Oedema peripheral—Galantamine—Alzheimer's disease	0.000507	0.0037	CcSEcCtD
Nicardipine—CALM2—forebrain—Alzheimer's disease	0.000503	0.01	CbGeAlD
Nicardipine—CALM1—forebrain—Alzheimer's disease	0.000501	0.00998	CbGeAlD
Nicardipine—CHRM5—nervous system—Alzheimer's disease	0.000499	0.00994	CbGeAlD
Nicardipine—Visual impairment—Galantamine—Alzheimer's disease	0.000496	0.00362	CcSEcCtD
Nicardipine—CACNB2—central nervous system—Alzheimer's disease	0.000495	0.00987	CbGeAlD
Nicardipine—Face oedema—Rivastigmine—Alzheimer's disease	0.000495	0.00361	CcSEcCtD
Nicardipine—CHRM4—brain—Alzheimer's disease	0.000488	0.00972	CbGeAlD
Nicardipine—Sweating increased—Donepezil—Alzheimer's disease	0.000486	0.00354	CcSEcCtD
Nicardipine—Angina pectoris—Donepezil—Alzheimer's disease	0.000486	0.00354	CcSEcCtD
Nicardipine—CACNB2—cerebellum—Alzheimer's disease	0.000484	0.00965	CbGeAlD
Nicardipine—CACNA2D1—nervous system—Alzheimer's disease	0.000483	0.00963	CbGeAlD
Nicardipine—CHRM5—central nervous system—Alzheimer's disease	0.00048	0.00957	CbGeAlD
Nicardipine—Tinnitus—Galantamine—Alzheimer's disease	0.00048	0.0035	CcSEcCtD
Nicardipine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000478	0.00349	CcSEcCtD
Nicardipine—Flushing—Galantamine—Alzheimer's disease	0.000478	0.00349	CcSEcCtD
Nicardipine—Hypokalaemia—Memantine—Alzheimer's disease	0.000477	0.00348	CcSEcCtD
Nicardipine—CHRM3—telencephalon—Alzheimer's disease	0.000473	0.00942	CbGeAlD
Nicardipine—ADRA1A—forebrain—Alzheimer's disease	0.000472	0.0094	CbGeAlD
Nicardipine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000468	0.00341	CcSEcCtD
Nicardipine—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000466	0.0034	CcSEcCtD
Nicardipine—CACNA2D1—central nervous system—Alzheimer's disease	0.000465	0.00927	CbGeAlD
Nicardipine—CALM2—telencephalon—Alzheimer's disease	0.000463	0.00922	CbGeAlD
Nicardipine—Pollakiuria—Donepezil—Alzheimer's disease	0.000461	0.00336	CcSEcCtD
Nicardipine—CALM1—telencephalon—Alzheimer's disease	0.00046	0.00918	CbGeAlD
Nicardipine—ADRA1B—nervous system—Alzheimer's disease	0.000456	0.00909	CbGeAlD
Nicardipine—CACNA2D1—cerebellum—Alzheimer's disease	0.000455	0.00906	CbGeAlD
Nicardipine—CACNA1D—nervous system—Alzheimer's disease	0.00045	0.00896	CbGeAlD
Nicardipine—ADRA1D—nervous system—Alzheimer's disease	0.000446	0.00889	CbGeAlD
Nicardipine—Angina pectoris—Memantine—Alzheimer's disease	0.000441	0.00322	CcSEcCtD
Nicardipine—Sweating increased—Memantine—Alzheimer's disease	0.000441	0.00322	CcSEcCtD
Nicardipine—Tension—Galantamine—Alzheimer's disease	0.00044	0.00321	CcSEcCtD
Nicardipine—ADRA1B—central nervous system—Alzheimer's disease	0.000439	0.00875	CbGeAlD
Nicardipine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000438	0.0032	CcSEcCtD
Nicardipine—Myocardial infarction—Donepezil—Alzheimer's disease	0.000436	0.00318	CcSEcCtD
Nicardipine—Nervousness—Galantamine—Alzheimer's disease	0.000435	0.00318	CcSEcCtD
Nicardipine—ADRA1A—telencephalon—Alzheimer's disease	0.000434	0.00865	CbGeAlD
Nicardipine—CACNA1D—central nervous system—Alzheimer's disease	0.000433	0.00863	CbGeAlD
Nicardipine—Conjunctivitis—Donepezil—Alzheimer's disease	0.000432	0.00315	CcSEcCtD
Nicardipine—Sweating increased—Rivastigmine—Alzheimer's disease	0.000431	0.00315	CcSEcCtD
Nicardipine—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000431	0.00315	CcSEcCtD
Nicardipine—ADRA1D—central nervous system—Alzheimer's disease	0.000429	0.00856	CbGeAlD
Nicardipine—Sweating—Donepezil—Alzheimer's disease	0.000426	0.00311	CcSEcCtD
Nicardipine—Haematuria—Donepezil—Alzheimer's disease	0.000424	0.00309	CcSEcCtD
Nicardipine—CACNA1D—cerebellum—Alzheimer's disease	0.000423	0.00843	CbGeAlD
Nicardipine—Vision blurred—Galantamine—Alzheimer's disease	0.000422	0.00308	CcSEcCtD
Nicardipine—Tremor—Galantamine—Alzheimer's disease	0.00042	0.00306	CcSEcCtD
Nicardipine—Pollakiuria—Memantine—Alzheimer's disease	0.000418	0.00305	CcSEcCtD
Nicardipine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000417	0.00304	CcSEcCtD
Nicardipine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000416	0.00303	CcSEcCtD
Nicardipine—CACNA1C—nervous system—Alzheimer's disease	0.000415	0.00827	CbGeAlD
Nicardipine—Agitation—Galantamine—Alzheimer's disease	0.000412	0.003	CcSEcCtD
Nicardipine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000409	0.00298	CcSEcCtD
Nicardipine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000408	0.00297	CcSEcCtD
Nicardipine—Malaise—Galantamine—Alzheimer's disease	0.000404	0.00295	CcSEcCtD
Nicardipine—Vertigo—Galantamine—Alzheimer's disease	0.000403	0.00294	CcSEcCtD
Nicardipine—Syncope—Galantamine—Alzheimer's disease	0.000402	0.00293	CcSEcCtD
Nicardipine—Rhinitis—Donepezil—Alzheimer's disease	0.0004	0.00292	CcSEcCtD
Nicardipine—CACNA1C—central nervous system—Alzheimer's disease	0.0004	0.00797	CbGeAlD
Nicardipine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000398	0.0029	CcSEcCtD
Nicardipine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000397	0.0029	CcSEcCtD
Nicardipine—Palpitations—Galantamine—Alzheimer's disease	0.000396	0.00289	CcSEcCtD
Nicardipine—Myocardial infarction—Memantine—Alzheimer's disease	0.000396	0.00289	CcSEcCtD
Nicardipine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000394	0.00287	CcSEcCtD
Nicardipine—CACNB2—brain—Alzheimer's disease	0.000393	0.00784	CbGeAlD
Nicardipine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000393	0.00287	CcSEcCtD
Nicardipine—Conjunctivitis—Memantine—Alzheimer's disease	0.000392	0.00286	CcSEcCtD
Nicardipine—CACNA1C—cerebellum—Alzheimer's disease	0.000391	0.00779	CbGeAlD
Nicardipine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000389	0.00284	CcSEcCtD
Nicardipine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000387	0.00282	CcSEcCtD
Nicardipine—Hypertension—Galantamine—Alzheimer's disease	0.000387	0.00282	CcSEcCtD
Nicardipine—Haematuria—Memantine—Alzheimer's disease	0.000385	0.00281	CcSEcCtD
Nicardipine—Visual impairment—Donepezil—Alzheimer's disease	0.000385	0.0028	CcSEcCtD
Nicardipine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000384	0.0028	CcSEcCtD
Nicardipine—Chest pain—Galantamine—Alzheimer's disease	0.000382	0.00278	CcSEcCtD
Nicardipine—Arthralgia—Galantamine—Alzheimer's disease	0.000382	0.00278	CcSEcCtD
Nicardipine—Myalgia—Galantamine—Alzheimer's disease	0.000382	0.00278	CcSEcCtD
Nicardipine—CHRM5—brain—Alzheimer's disease	0.000381	0.0076	CbGeAlD
Nicardipine—Anxiety—Galantamine—Alzheimer's disease	0.00038	0.00277	CcSEcCtD
Nicardipine—ABCB1—blood vessel—Alzheimer's disease	0.000379	0.00755	CbGeAlD
Nicardipine—Sinusitis—Memantine—Alzheimer's disease	0.000379	0.00276	CcSEcCtD
Nicardipine—Sweating—Rivastigmine—Alzheimer's disease	0.000379	0.00276	CcSEcCtD
Nicardipine—Discomfort—Galantamine—Alzheimer's disease	0.000377	0.00275	CcSEcCtD
Nicardipine—Haematuria—Rivastigmine—Alzheimer's disease	0.000376	0.00275	CcSEcCtD
Nicardipine—Clevidipine—BCHE—Alzheimer's disease	0.000374	0.151	CrCbGaD
Nicardipine—Dry mouth—Galantamine—Alzheimer's disease	0.000373	0.00272	CcSEcCtD
Nicardipine—Tinnitus—Donepezil—Alzheimer's disease	0.000372	0.00271	CcSEcCtD
Nicardipine—Sinusitis—Rivastigmine—Alzheimer's disease	0.00037	0.0027	CcSEcCtD
Nicardipine—CACNA2D1—brain—Alzheimer's disease	0.000369	0.00736	CbGeAlD
Nicardipine—Confusional state—Galantamine—Alzheimer's disease	0.000369	0.00269	CcSEcCtD
Nicardipine—Rhinitis—Memantine—Alzheimer's disease	0.000363	0.00265	CcSEcCtD
Nicardipine—Hypoaesthesia—Memantine—Alzheimer's disease	0.00036	0.00263	CcSEcCtD
Nicardipine—Shock—Galantamine—Alzheimer's disease	0.00036	0.00263	CcSEcCtD
Nicardipine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000358	0.00261	CcSEcCtD
Nicardipine—Tachycardia—Galantamine—Alzheimer's disease	0.000357	0.0026	CcSEcCtD
Nicardipine—Oedema peripheral—Memantine—Alzheimer's disease	0.000357	0.0026	CcSEcCtD
Nicardipine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000355	0.00259	CcSEcCtD
Nicardipine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000354	0.00258	CcSEcCtD
Nicardipine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000353	0.00257	CcSEcCtD
Nicardipine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000349	0.00255	CcSEcCtD
Nicardipine—Visual impairment—Memantine—Alzheimer's disease	0.000349	0.00255	CcSEcCtD
Nicardipine—ADRA1B—brain—Alzheimer's disease	0.000348	0.00694	CbGeAlD
Nicardipine—CACNA1D—brain—Alzheimer's disease	0.000344	0.00685	CbGeAlD
Nicardipine—CHRM2—nervous system—Alzheimer's disease	0.000342	0.00683	CbGeAlD
Nicardipine—Hypotension—Galantamine—Alzheimer's disease	0.000342	0.00249	CcSEcCtD
Nicardipine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000342	0.00249	CcSEcCtD
Nicardipine—Tension—Donepezil—Alzheimer's disease	0.000341	0.00249	CcSEcCtD
Nicardipine—ADRA1D—brain—Alzheimer's disease	0.000341	0.00679	CbGeAlD
Nicardipine—Tinnitus—Memantine—Alzheimer's disease	0.000338	0.00246	CcSEcCtD
Nicardipine—Nervousness—Donepezil—Alzheimer's disease	0.000337	0.00246	CcSEcCtD
Nicardipine—Flushing—Memantine—Alzheimer's disease	0.000336	0.00245	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000333	0.00243	CcSEcCtD
Nicardipine—Insomnia—Galantamine—Alzheimer's disease	0.000331	0.00241	CcSEcCtD
Nicardipine—Tinnitus—Rivastigmine—Alzheimer's disease	0.00033	0.00241	CcSEcCtD
Nicardipine—CHRM2—central nervous system—Alzheimer's disease	0.00033	0.00657	CbGeAlD
Nicardipine—Flushing—Rivastigmine—Alzheimer's disease	0.000329	0.0024	CcSEcCtD
Nicardipine—Paraesthesia—Galantamine—Alzheimer's disease	0.000328	0.0024	CcSEcCtD
Nicardipine—Vision blurred—Donepezil—Alzheimer's disease	0.000327	0.00239	CcSEcCtD
Nicardipine—CALM3—cerebellum—Alzheimer's disease	0.000327	0.00652	CbGeAlD
Nicardipine—Tremor—Donepezil—Alzheimer's disease	0.000325	0.00237	CcSEcCtD
Nicardipine—Somnolence—Galantamine—Alzheimer's disease	0.000325	0.00237	CcSEcCtD
Nicardipine—CYP2E1—telencephalon—Alzheimer's disease	0.000323	0.00643	CbGeAlD
Nicardipine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000322	0.00235	CcSEcCtD
Nicardipine—Dyspepsia—Galantamine—Alzheimer's disease	0.000322	0.00235	CcSEcCtD
Nicardipine—Agitation—Donepezil—Alzheimer's disease	0.000319	0.00233	CcSEcCtD
Nicardipine—CACNA1C—brain—Alzheimer's disease	0.000317	0.00632	CbGeAlD
Nicardipine—Malaise—Donepezil—Alzheimer's disease	0.000313	0.00228	CcSEcCtD
Nicardipine—Constipation—Galantamine—Alzheimer's disease	0.000313	0.00228	CcSEcCtD
Nicardipine—Vertigo—Donepezil—Alzheimer's disease	0.000312	0.00228	CcSEcCtD
Nicardipine—CHRM1—nervous system—Alzheimer's disease	0.000312	0.00621	CbGeAlD
Nicardipine—Syncope—Donepezil—Alzheimer's disease	0.000312	0.00227	CcSEcCtD
Nicardipine—Tension—Memantine—Alzheimer's disease	0.00031	0.00226	CcSEcCtD
Nicardipine—Nervousness—Memantine—Alzheimer's disease	0.000306	0.00223	CcSEcCtD
Nicardipine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000305	0.00223	CcSEcCtD
Nicardipine—Tension—Rivastigmine—Alzheimer's disease	0.000303	0.00221	CcSEcCtD
Nicardipine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000301	0.0022	CcSEcCtD
Nicardipine—CHRM1—central nervous system—Alzheimer's disease	0.0003	0.00598	CbGeAlD
Nicardipine—Hypertension—Donepezil—Alzheimer's disease	0.0003	0.00219	CcSEcCtD
Nicardipine—Nervousness—Rivastigmine—Alzheimer's disease	0.0003	0.00219	CcSEcCtD
Nicardipine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000299	0.00218	CcSEcCtD
Nicardipine—Vision blurred—Memantine—Alzheimer's disease	0.000297	0.00217	CcSEcCtD
Nicardipine—Myalgia—Donepezil—Alzheimer's disease	0.000296	0.00216	CcSEcCtD
Nicardipine—Chest pain—Donepezil—Alzheimer's disease	0.000296	0.00216	CcSEcCtD
Nicardipine—Arthralgia—Donepezil—Alzheimer's disease	0.000296	0.00216	CcSEcCtD
Nicardipine—Tremor—Memantine—Alzheimer's disease	0.000295	0.00216	CcSEcCtD
Nicardipine—Anxiety—Donepezil—Alzheimer's disease	0.000295	0.00215	CcSEcCtD
Nicardipine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000293	0.00213	CcSEcCtD
Nicardipine—Discomfort—Donepezil—Alzheimer's disease	0.000292	0.00213	CcSEcCtD
Nicardipine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000291	0.00212	CcSEcCtD
Nicardipine—Agitation—Memantine—Alzheimer's disease	0.00029	0.00211	CcSEcCtD
Nicardipine—Dry mouth—Donepezil—Alzheimer's disease	0.000289	0.00211	CcSEcCtD
Nicardipine—Abdominal pain—Galantamine—Alzheimer's disease	0.000289	0.00211	CcSEcCtD
Nicardipine—Body temperature increased—Galantamine—Alzheimer's disease	0.000289	0.00211	CcSEcCtD
Nicardipine—Tremor—Rivastigmine—Alzheimer's disease	0.000289	0.00211	CcSEcCtD
Nicardipine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000286	0.00209	CcSEcCtD
Nicardipine—Confusional state—Donepezil—Alzheimer's disease	0.000286	0.00209	CcSEcCtD
Nicardipine—Malaise—Memantine—Alzheimer's disease	0.000284	0.00207	CcSEcCtD
Nicardipine—Agitation—Rivastigmine—Alzheimer's disease	0.000284	0.00207	CcSEcCtD
Nicardipine—Oedema—Donepezil—Alzheimer's disease	0.000284	0.00207	CcSEcCtD
Nicardipine—Vertigo—Memantine—Alzheimer's disease	0.000283	0.00207	CcSEcCtD
Nicardipine—Syncope—Memantine—Alzheimer's disease	0.000283	0.00206	CcSEcCtD
Nicardipine—Infection—Donepezil—Alzheimer's disease	0.000282	0.00205	CcSEcCtD
Nicardipine—CHRM3—nervous system—Alzheimer's disease	0.000279	0.00556	CbGeAlD
Nicardipine—Shock—Donepezil—Alzheimer's disease	0.000279	0.00203	CcSEcCtD
Nicardipine—Palpitations—Memantine—Alzheimer's disease	0.000279	0.00203	CcSEcCtD
Nicardipine—Malaise—Rivastigmine—Alzheimer's disease	0.000278	0.00203	CcSEcCtD
Nicardipine—CYP2D6—forebrain—Alzheimer's disease	0.000278	0.00554	CbGeAlD
Nicardipine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000278	0.00202	CcSEcCtD
Nicardipine—Vertigo—Rivastigmine—Alzheimer's disease	0.000277	0.00202	CcSEcCtD
Nicardipine—Loss of consciousness—Memantine—Alzheimer's disease	0.000277	0.00202	CcSEcCtD
Nicardipine—Syncope—Rivastigmine—Alzheimer's disease	0.000277	0.00202	CcSEcCtD
Nicardipine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000274	0.002	CcSEcCtD
Nicardipine—CALM2—nervous system—Alzheimer's disease	0.000273	0.00544	CbGeAlD
Nicardipine—Palpitations—Rivastigmine—Alzheimer's disease	0.000273	0.00199	CcSEcCtD
Nicardipine—Hypertension—Memantine—Alzheimer's disease	0.000272	0.00199	CcSEcCtD
Nicardipine—CALM1—nervous system—Alzheimer's disease	0.000272	0.00542	CbGeAlD
Nicardipine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000271	0.00198	CcSEcCtD
Nicardipine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00027	0.00197	CcSEcCtD
Nicardipine—CHRM3—central nervous system—Alzheimer's disease	0.000269	0.00535	CbGeAlD
Nicardipine—Chest pain—Memantine—Alzheimer's disease	0.000269	0.00196	CcSEcCtD
Nicardipine—Arthralgia—Memantine—Alzheimer's disease	0.000269	0.00196	CcSEcCtD
Nicardipine—Myalgia—Memantine—Alzheimer's disease	0.000269	0.00196	CcSEcCtD
Nicardipine—Anxiety—Memantine—Alzheimer's disease	0.000268	0.00195	CcSEcCtD
Nicardipine—Hypertension—Rivastigmine—Alzheimer's disease	0.000266	0.00194	CcSEcCtD
Nicardipine—CALM3—brain—Alzheimer's disease	0.000266	0.0053	CbGeAlD
Nicardipine—Discomfort—Memantine—Alzheimer's disease	0.000265	0.00194	CcSEcCtD
Nicardipine—Hypotension—Donepezil—Alzheimer's disease	0.000265	0.00193	CcSEcCtD
Nicardipine—CALM2—central nervous system—Alzheimer's disease	0.000263	0.00524	CbGeAlD
Nicardipine—Myalgia—Rivastigmine—Alzheimer's disease	0.000263	0.00192	CcSEcCtD
Nicardipine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000263	0.00192	CcSEcCtD
Nicardipine—Chest pain—Rivastigmine—Alzheimer's disease	0.000263	0.00192	CcSEcCtD
Nicardipine—Dry mouth—Memantine—Alzheimer's disease	0.000263	0.00192	CcSEcCtD
Nicardipine—Asthenia—Galantamine—Alzheimer's disease	0.000262	0.00191	CcSEcCtD
Nicardipine—Anxiety—Rivastigmine—Alzheimer's disease	0.000262	0.00191	CcSEcCtD
Nicardipine—CHRM2—brain—Alzheimer's disease	0.000262	0.00522	CbGeAlD
Nicardipine—CALM1—central nervous system—Alzheimer's disease	0.000262	0.00522	CbGeAlD
Nicardipine—Confusional state—Memantine—Alzheimer's disease	0.00026	0.00189	CcSEcCtD
Nicardipine—Discomfort—Rivastigmine—Alzheimer's disease	0.00026	0.00189	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000258	0.00188	CcSEcCtD
Nicardipine—Lercanidipine—CYP2D6—Alzheimer's disease	0.000258	0.104	CrCbGaD
Nicardipine—Oedema—Memantine—Alzheimer's disease	0.000257	0.00188	CcSEcCtD
Nicardipine—CALM2—cerebellum—Alzheimer's disease	0.000257	0.00512	CbGeAlD
Nicardipine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000257	0.00187	CcSEcCtD
Nicardipine—Insomnia—Donepezil—Alzheimer's disease	0.000256	0.00187	CcSEcCtD
Nicardipine—ADRA1A—nervous system—Alzheimer's disease	0.000256	0.0051	CbGeAlD
Nicardipine—CALM1—cerebellum—Alzheimer's disease	0.000256	0.0051	CbGeAlD
Nicardipine—Infection—Memantine—Alzheimer's disease	0.000256	0.00187	CcSEcCtD
Nicardipine—CYP2D6—telencephalon—Alzheimer's disease	0.000256	0.00509	CbGeAlD
Nicardipine—Paraesthesia—Donepezil—Alzheimer's disease	0.000255	0.00186	CcSEcCtD
Nicardipine—Confusional state—Rivastigmine—Alzheimer's disease	0.000254	0.00185	CcSEcCtD
Nicardipine—Shock—Memantine—Alzheimer's disease	0.000253	0.00185	CcSEcCtD
Nicardipine—Dyspnoea—Donepezil—Alzheimer's disease	0.000253	0.00184	CcSEcCtD
Nicardipine—Somnolence—Donepezil—Alzheimer's disease	0.000252	0.00184	CcSEcCtD
Nicardipine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000252	0.00184	CcSEcCtD
Nicardipine—Oedema—Rivastigmine—Alzheimer's disease	0.000252	0.00184	CcSEcCtD
Nicardipine—Tachycardia—Memantine—Alzheimer's disease	0.000251	0.00183	CcSEcCtD
Nicardipine—Diarrhoea—Galantamine—Alzheimer's disease	0.00025	0.00183	CcSEcCtD
Nicardipine—Infection—Rivastigmine—Alzheimer's disease	0.00025	0.00182	CcSEcCtD
Nicardipine—Dyspepsia—Donepezil—Alzheimer's disease	0.00025	0.00182	CcSEcCtD
Nicardipine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000249	0.00182	CcSEcCtD
Nicardipine—Shock—Rivastigmine—Alzheimer's disease	0.000248	0.00181	CcSEcCtD
Nicardipine—ADRA1A—central nervous system—Alzheimer's disease	0.000247	0.00491	CbGeAlD
Nicardipine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000247	0.0018	CcSEcCtD
Nicardipine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000246	0.00179	CcSEcCtD
Nicardipine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000243	0.00178	CcSEcCtD
Nicardipine—Constipation—Donepezil—Alzheimer's disease	0.000242	0.00177	CcSEcCtD
Nicardipine—Pain—Donepezil—Alzheimer's disease	0.000242	0.00177	CcSEcCtD
Nicardipine—Dizziness—Galantamine—Alzheimer's disease	0.000242	0.00176	CcSEcCtD
Nicardipine—ADRA1A—cerebellum—Alzheimer's disease	0.000241	0.0048	CbGeAlD
Nicardipine—Hypotension—Memantine—Alzheimer's disease	0.000241	0.00175	CcSEcCtD
Nicardipine—CHRM1—brain—Alzheimer's disease	0.000238	0.00475	CbGeAlD
Nicardipine—Hypotension—Rivastigmine—Alzheimer's disease	0.000235	0.00172	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000235	0.00171	CcSEcCtD
Nicardipine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000234	0.0017	CcSEcCtD
Nicardipine—Insomnia—Memantine—Alzheimer's disease	0.000233	0.0017	CcSEcCtD
Nicardipine—Vomiting—Galantamine—Alzheimer's disease	0.000233	0.0017	CcSEcCtD
Nicardipine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000232	0.00169	CcSEcCtD
Nicardipine—Paraesthesia—Memantine—Alzheimer's disease	0.000231	0.00169	CcSEcCtD
Nicardipine—Rash—Galantamine—Alzheimer's disease	0.000231	0.00168	CcSEcCtD
Nicardipine—Dermatitis—Galantamine—Alzheimer's disease	0.00023	0.00168	CcSEcCtD
Nicardipine—Dyspnoea—Memantine—Alzheimer's disease	0.000229	0.00167	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000229	0.00167	CcSEcCtD
Nicardipine—Headache—Galantamine—Alzheimer's disease	0.000229	0.00167	CcSEcCtD
Nicardipine—Somnolence—Memantine—Alzheimer's disease	0.000229	0.00167	CcSEcCtD
Nicardipine—Insomnia—Rivastigmine—Alzheimer's disease	0.000228	0.00166	CcSEcCtD
Nicardipine—Dyspepsia—Memantine—Alzheimer's disease	0.000227	0.00165	CcSEcCtD
Nicardipine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000226	0.00165	CcSEcCtD
Nicardipine—ABCB1—embryo—Alzheimer's disease	0.000226	0.0045	CbGeAlD
Nicardipine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000225	0.00164	CcSEcCtD
Nicardipine—Abdominal pain—Donepezil—Alzheimer's disease	0.000224	0.00163	CcSEcCtD
Nicardipine—Body temperature increased—Donepezil—Alzheimer's disease	0.000224	0.00163	CcSEcCtD
Nicardipine—Somnolence—Rivastigmine—Alzheimer's disease	0.000224	0.00163	CcSEcCtD
Nicardipine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000222	0.00162	CcSEcCtD
Nicardipine—Pain—Memantine—Alzheimer's disease	0.00022	0.00161	CcSEcCtD
Nicardipine—Constipation—Memantine—Alzheimer's disease	0.00022	0.00161	CcSEcCtD
Nicardipine—Nausea—Galantamine—Alzheimer's disease	0.000217	0.00158	CcSEcCtD
Nicardipine—Pain—Rivastigmine—Alzheimer's disease	0.000215	0.00157	CcSEcCtD
Nicardipine—Constipation—Rivastigmine—Alzheimer's disease	0.000215	0.00157	CcSEcCtD
Nicardipine—CHRM3—brain—Alzheimer's disease	0.000213	0.00425	CbGeAlD
Nicardipine—Feeling abnormal—Memantine—Alzheimer's disease	0.000212	0.00155	CcSEcCtD
Nicardipine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00021	0.00154	CcSEcCtD
Nicardipine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000209	0.00152	CcSEcCtD
Nicardipine—CALM2—brain—Alzheimer's disease	0.000209	0.00416	CbGeAlD
Nicardipine—CALM1—brain—Alzheimer's disease	0.000208	0.00414	CbGeAlD
Nicardipine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000208	0.00151	CcSEcCtD
Nicardipine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000206	0.0015	CcSEcCtD
Nicardipine—Clevidipine—CYP2D6—Alzheimer's disease	0.000205	0.0831	CrCbGaD
Nicardipine—Abdominal pain—Memantine—Alzheimer's disease	0.000203	0.00148	CcSEcCtD
Nicardipine—Body temperature increased—Memantine—Alzheimer's disease	0.000203	0.00148	CcSEcCtD
Nicardipine—Asthenia—Donepezil—Alzheimer's disease	0.000203	0.00148	CcSEcCtD
Nicardipine—CYP2B6—nervous system—Alzheimer's disease	0.000203	0.00405	CbGeAlD
Nicardipine—ABCB1—forebrain—Alzheimer's disease	0.0002	0.00398	CbGeAlD
Nicardipine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000199	0.00145	CcSEcCtD
Nicardipine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000199	0.00145	CcSEcCtD
Nicardipine—ADRA1A—brain—Alzheimer's disease	0.000196	0.0039	CbGeAlD
Nicardipine—CYP2B6—central nervous system—Alzheimer's disease	0.000195	0.0039	CbGeAlD
Nicardipine—Diarrhoea—Donepezil—Alzheimer's disease	0.000194	0.00141	CcSEcCtD
Nicardipine—CYP2E1—nervous system—Alzheimer's disease	0.000191	0.0038	CbGeAlD
Nicardipine—Hypersensitivity—Memantine—Alzheimer's disease	0.00019	0.00138	CcSEcCtD
Nicardipine—Dizziness—Donepezil—Alzheimer's disease	0.000187	0.00137	CcSEcCtD
Nicardipine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000186	0.00135	CcSEcCtD
Nicardipine—Asthenia—Memantine—Alzheimer's disease	0.000185	0.00135	CcSEcCtD
Nicardipine—ABCB1—telencephalon—Alzheimer's disease	0.000184	0.00366	CbGeAlD
Nicardipine—CYP2E1—central nervous system—Alzheimer's disease	0.000183	0.00366	CbGeAlD
Nicardipine—Asthenia—Rivastigmine—Alzheimer's disease	0.000181	0.00132	CcSEcCtD
Nicardipine—Vomiting—Donepezil—Alzheimer's disease	0.00018	0.00131	CcSEcCtD
Nicardipine—CYP2E1—cerebellum—Alzheimer's disease	0.000179	0.00357	CbGeAlD
Nicardipine—Rash—Donepezil—Alzheimer's disease	0.000179	0.0013	CcSEcCtD
Nicardipine—Dermatitis—Donepezil—Alzheimer's disease	0.000179	0.0013	CcSEcCtD
Nicardipine—Headache—Donepezil—Alzheimer's disease	0.000178	0.0013	CcSEcCtD
Nicardipine—Diarrhoea—Memantine—Alzheimer's disease	0.000176	0.00128	CcSEcCtD
Nicardipine—CYP2C8—brain—Alzheimer's disease	0.000173	0.00345	CbGeAlD
Nicardipine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000172	0.00126	CcSEcCtD
Nicardipine—Dizziness—Memantine—Alzheimer's disease	0.00017	0.00124	CcSEcCtD
Nicardipine—Nausea—Donepezil—Alzheimer's disease	0.000168	0.00123	CcSEcCtD
Nicardipine—Dizziness—Rivastigmine—Alzheimer's disease	0.000167	0.00121	CcSEcCtD
Nicardipine—Vomiting—Memantine—Alzheimer's disease	0.000164	0.00119	CcSEcCtD
Nicardipine—Rash—Memantine—Alzheimer's disease	0.000162	0.00118	CcSEcCtD
Nicardipine—Dermatitis—Memantine—Alzheimer's disease	0.000162	0.00118	CcSEcCtD
Nicardipine—Headache—Memantine—Alzheimer's disease	0.000161	0.00118	CcSEcCtD
Nicardipine—Vomiting—Rivastigmine—Alzheimer's disease	0.00016	0.00117	CcSEcCtD
Nicardipine—Rash—Rivastigmine—Alzheimer's disease	0.000159	0.00116	CcSEcCtD
Nicardipine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000159	0.00116	CcSEcCtD
Nicardipine—Amlodipine—CYP2D6—Alzheimer's disease	0.000159	0.0641	CrCbGaD
Nicardipine—Headache—Rivastigmine—Alzheimer's disease	0.000158	0.00115	CcSEcCtD
Nicardipine—CYP2B6—brain—Alzheimer's disease	0.000155	0.00309	CbGeAlD
Nicardipine—CYP3A4—nervous system—Alzheimer's disease	0.000153	0.00306	CbGeAlD
Nicardipine—Nausea—Memantine—Alzheimer's disease	0.000153	0.00112	CcSEcCtD
Nicardipine—CYP2D6—nervous system—Alzheimer's disease	0.000151	0.00301	CbGeAlD
Nicardipine—Nausea—Rivastigmine—Alzheimer's disease	0.00015	0.00109	CcSEcCtD
Nicardipine—CYP3A4—central nervous system—Alzheimer's disease	0.000148	0.00294	CbGeAlD
Nicardipine—Felodipine—CYP2D6—Alzheimer's disease	0.000147	0.0593	CrCbGaD
Nicardipine—CYP2E1—brain—Alzheimer's disease	0.000146	0.0029	CbGeAlD
Nicardipine—CYP2D6—central nervous system—Alzheimer's disease	0.000145	0.00289	CbGeAlD
Nicardipine—CYP2D6—cerebellum—Alzheimer's disease	0.000142	0.00283	CbGeAlD
Nicardipine—Nifedipine—CYP2D6—Alzheimer's disease	0.000142	0.0573	CrCbGaD
Nicardipine—CYP2D6—brain—Alzheimer's disease	0.000115	0.0023	CbGeAlD
Nicardipine—ABCB1—nervous system—Alzheimer's disease	0.000109	0.00216	CbGeAlD
Nicardipine—ABCB1—central nervous system—Alzheimer's disease	0.000104	0.00208	CbGeAlD
Nicardipine—ABCB1—cerebellum—Alzheimer's disease	0.000102	0.00204	CbGeAlD
Nicardipine—ABCB1—brain—Alzheimer's disease	8.29e-05	0.00165	CbGeAlD
Nicardipine—CALM2—Metabolism—INS—Alzheimer's disease	1.76e-06	1.33e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	1.76e-06	1.33e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL1B—Alzheimer's disease	1.75e-06	1.33e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—AKT1—Alzheimer's disease	1.75e-06	1.32e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—AKT1—Alzheimer's disease	1.75e-06	1.32e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.74e-06	1.32e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PTGS2—Alzheimer's disease	1.74e-06	1.32e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PTGS2—Alzheimer's disease	1.74e-06	1.32e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	1.74e-06	1.32e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	1.73e-06	1.31e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.73e-06	1.31e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CALM1—Alzheimer's disease	1.73e-06	1.31e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—APOE—Alzheimer's disease	1.72e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—APOE—Alzheimer's disease	1.72e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—LEP—Alzheimer's disease	1.72e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—LEP—Alzheimer's disease	1.72e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	1.71e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—IL6—Alzheimer's disease	1.71e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—IL6—Alzheimer's disease	1.71e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CAV1—Alzheimer's disease	1.71e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CAV1—Alzheimer's disease	1.71e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ESR1—Alzheimer's disease	1.7e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL1B—Alzheimer's disease	1.7e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL1B—Alzheimer's disease	1.7e-06	1.28e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—AKT1—Alzheimer's disease	1.69e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PTGS2—Alzheimer's disease	1.68e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PTGS2—Alzheimer's disease	1.68e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—F2—Alzheimer's disease	1.68e-06	1.27e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—IL6—Alzheimer's disease	1.68e-06	1.27e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	1.66e-06	1.26e-05	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—AKT1—Alzheimer's disease	1.66e-06	1.26e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	1.66e-06	1.26e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	1.66e-06	1.25e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—APOE—Alzheimer's disease	1.65e-06	1.25e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.65e-06	1.25e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ESR1—Alzheimer's disease	1.64e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ESR1—Alzheimer's disease	1.64e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NOTCH1—Alzheimer's disease	1.64e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	1.64e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.64e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	1.63e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.63e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—AKT1—Alzheimer's disease	1.63e-06	1.23e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—F2—Alzheimer's disease	1.62e-06	1.23e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—F2—Alzheimer's disease	1.62e-06	1.23e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.62e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.62e-06	1.22e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—APOE—Alzheimer's disease	1.61e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PPARG—Alzheimer's disease	1.61e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—MAPK8—Alzheimer's disease	1.61e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	1.6e-06	1.21e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.6e-06	1.21e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.6e-06	1.21e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.6e-06	1.21e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—NOS3—Alzheimer's disease	1.59e-06	1.21e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	1.59e-06	1.2e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.59e-06	1.2e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.59e-06	1.2e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—INS—Alzheimer's disease	1.58e-06	1.2e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.58e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—AKT1—Alzheimer's disease	1.57e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—AKT1—Alzheimer's disease	1.57e-06	1.19e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.57e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	1.57e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—AKT1—Alzheimer's disease	1.56e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.56e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—MAPK8—Alzheimer's disease	1.56e-06	1.18e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—MAPK8—Alzheimer's disease	1.56e-06	1.18e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—AKT1—Alzheimer's disease	1.55e-06	1.17e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—NOS3—Alzheimer's disease	1.54e-06	1.17e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—NOS3—Alzheimer's disease	1.54e-06	1.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—GSK3B—Alzheimer's disease	1.54e-06	1.17e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.54e-06	1.16e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CREB1—Alzheimer's disease	1.53e-06	1.16e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.53e-06	1.15e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—INS—Alzheimer's disease	1.52e-06	1.15e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.52e-06	1.15e-05	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.52e-06	1.15e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.51e-06	1.14e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—AKT1—Alzheimer's disease	1.51e-06	1.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—AKT1—Alzheimer's disease	1.51e-06	1.14e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.51e-06	1.14e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.51e-06	1.14e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.51e-06	1.14e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	1.5e-06	1.14e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	1.5e-06	1.14e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	1.5e-06	1.13e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCL2—Alzheimer's disease	1.5e-06	1.13e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	1.49e-06	1.13e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.49e-06	1.13e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—GSK3B—Alzheimer's disease	1.49e-06	1.13e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—GSK3B—Alzheimer's disease	1.49e-06	1.13e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CREB1—Alzheimer's disease	1.48e-06	1.12e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CREB1—Alzheimer's disease	1.48e-06	1.12e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—INS—Alzheimer's disease	1.47e-06	1.11e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—INS—Alzheimer's disease	1.47e-06	1.11e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IGF1—Alzheimer's disease	1.47e-06	1.11e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	1.47e-06	1.11e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.46e-06	1.11e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTGS2—Alzheimer's disease	1.46e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCL2—Alzheimer's disease	1.45e-06	1.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCL2—Alzheimer's disease	1.45e-06	1.09e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.44e-06	1.09e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IGF1—Alzheimer's disease	1.42e-06	1.08e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IGF1—Alzheimer's disease	1.42e-06	1.08e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—INS—Alzheimer's disease	1.41e-06	1.07e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTGS2—Alzheimer's disease	1.41e-06	1.07e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTGS2—Alzheimer's disease	1.41e-06	1.07e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.41e-06	1.07e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.41e-06	1.06e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—NOS3—Alzheimer's disease	1.39e-06	1.05e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.38e-06	1.05e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—INS—Alzheimer's disease	1.38e-06	1.04e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.38e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.37e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.36e-06	1.03e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.36e-06	1.03e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.35e-06	1.02e-05	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.35e-06	1.02e-05	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.35e-06	1.02e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.35e-06	1.02e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.34e-06	1.02e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.34e-06	1.01e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.34e-06	1.01e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NOS3—Alzheimer's disease	1.33e-06	1.01e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.33e-06	1.01e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.33e-06	1e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.32e-06	1e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.31e-06	9.93e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.3e-06	9.85e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—INS—Alzheimer's disease	1.3e-06	9.83e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.3e-06	9.81e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NOS3—Alzheimer's disease	1.29e-06	9.76e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NOS3—Alzheimer's disease	1.29e-06	9.76e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.29e-06	9.76e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—INS—Alzheimer's disease	1.29e-06	9.74e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.28e-06	9.65e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	1.27e-06	9.6e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—TGFB1—Alzheimer's disease	1.26e-06	9.53e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.25e-06	9.43e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.24e-06	9.41e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.24e-06	9.4e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.24e-06	9.38e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.24e-06	9.37e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.24e-06	9.35e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.23e-06	9.31e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.23e-06	9.29e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.23e-06	9.29e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.22e-06	9.26e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—Alzheimer's disease	1.22e-06	9.22e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—Alzheimer's disease	1.22e-06	9.22e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.21e-06	9.14e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.19e-06	8.97e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.18e-06	8.93e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.17e-06	8.86e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	1.16e-06	8.79e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.15e-06	8.71e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.15e-06	8.68e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.14e-06	8.62e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.14e-06	8.6e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.13e-06	8.57e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.13e-06	8.57e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—Alzheimer's disease	1.13e-06	8.57e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.13e-06	8.55e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.13e-06	8.54e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—Alzheimer's disease	1.12e-06	8.51e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.11e-06	8.36e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—Alzheimer's disease	1.1e-06	8.29e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—Alzheimer's disease	1.1e-06	8.29e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.09e-06	8.24e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—Alzheimer's disease	1.09e-06	8.23e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—Alzheimer's disease	1.09e-06	8.23e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.07e-06	8.08e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	1.06e-06	8.04e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.06e-06	7.99e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.05e-06	7.97e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	1.04e-06	7.89e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.04e-06	7.89e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.04e-06	7.88e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.04e-06	7.87e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.04e-06	7.87e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.04e-06	7.85e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.03e-06	7.81e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—Alzheimer's disease	1.03e-06	7.77e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.01e-06	7.61e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.01e-06	7.61e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—Alzheimer's disease	1e-06	7.59e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—Alzheimer's disease	1e-06	7.59e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	9.97e-07	7.55e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—Alzheimer's disease	9.94e-07	7.52e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—Alzheimer's disease	9.94e-07	7.52e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—APOE—Alzheimer's disease	9.94e-07	7.52e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.85e-07	7.45e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	9.81e-07	7.42e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	9.64e-07	7.29e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—Alzheimer's disease	9.61e-07	7.27e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—Alzheimer's disease	9.49e-07	7.18e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—Alzheimer's disease	9.48e-07	7.17e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—Alzheimer's disease	9.29e-07	7.03e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—Alzheimer's disease	9.29e-07	7.03e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—Alzheimer's disease	9.18e-07	6.94e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—Alzheimer's disease	9.18e-07	6.94e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—Alzheimer's disease	9.17e-07	6.94e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—Alzheimer's disease	9.17e-07	6.94e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	8.82e-07	6.68e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—Alzheimer's disease	8.82e-07	6.67e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—Alzheimer's disease	8.76e-07	6.62e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—Alzheimer's disease	8.75e-07	6.62e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	8.7e-07	6.58e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	8.67e-07	6.56e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.66e-07	6.55e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	8.59e-07	6.5e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	8.56e-07	6.48e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—Alzheimer's disease	8.53e-07	6.45e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—Alzheimer's disease	8.53e-07	6.45e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—INS—Alzheimer's disease	8.49e-07	6.42e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—Alzheimer's disease	8.47e-07	6.41e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—Alzheimer's disease	8.47e-07	6.41e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	8.14e-07	6.16e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	7.96e-07	6.02e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	7.94e-07	6e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	7.86e-07	5.95e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	7.84e-07	5.93e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	7.53e-07	5.7e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.45e-07	5.63e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	7.38e-07	5.58e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—Alzheimer's disease	7.36e-07	5.57e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	7.34e-07	5.56e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—Alzheimer's disease	7.33e-07	5.55e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	7.32e-07	5.54e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—Alzheimer's disease	7.26e-07	5.49e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	7.25e-07	5.49e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	7.23e-07	5.47e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—Alzheimer's disease	7.09e-07	5.36e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—Alzheimer's disease	7.09e-07	5.36e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—Alzheimer's disease	7.02e-07	5.31e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—Alzheimer's disease	7.02e-07	5.31e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.81e-07	5.15e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—Alzheimer's disease	6.64e-07	5.03e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—Alzheimer's disease	6.43e-07	4.86e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—Alzheimer's disease	6.43e-07	4.86e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—Alzheimer's disease	6.38e-07	4.82e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—Alzheimer's disease	6.13e-07	4.64e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—Alzheimer's disease	5.93e-07	4.49e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—Alzheimer's disease	5.93e-07	4.49e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	5.69e-07	4.31e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.56e-07	4.2e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	5.24e-07	3.96e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	5.19e-07	3.93e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.42e-07	2.59e-06	CbGpPWpGaD
